Yayınlar & Eserler

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia Kronik Miyeloid Lösemi Tanılı Hastada Nilotinib ile İlişkili Çoklu Sessiz Arteriyel Darlık

Tokatlı M., Ismayilov R., ÇINAR O. E., HAZNEDAROĞLU İ. C.
Turkish Journal of Hematology , cilt.41, sa.1, ss.59-60, 2024 (SCI-Expanded) identifier identifier

Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.

TÜRK S., Yanpar H., Baesmat A. S., Canli S., ÇINAR O. E., MALKAN Ü. Y., et al.
Heliyon , cilt.9, sa.9, 2023 (SCI-Expanded) identifier identifier

The effects of Ankaferd hemostat on preventing oral mucositis in colorectal cancer patients receiving chemotherapy

Karacan Y., YILDIZ H., EVRENSEL T., HAZNEDAROĞLU İ. C.
Supportive Care in Cancer , cilt.31, sa.7, 2023 (SCI-Expanded) identifier identifier

Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s Dysfunction

TÜRK S., Baesmat A. S., YILMAZ A., MALKAN Ü. Y., TÜRK C., HAZNEDAROĞLU İ. C., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.2, ss.66-74, 2023 (SCI-Expanded) identifier

Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome

ŞENEL E., TÜRK S., MALKAN Ü. Y., Peker M. Ç., TÜRK C., GÜNER H. R., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1194-1204, 2023 (SCI-Expanded) Creative Commons License identifier identifier

A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded) identifier identifier identifier identifier

Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19 Patients in the Intensive Care Unit: A Case-Control Study

Canbaz H., İdiz U. O., Cankar Dal H., Kaçıroğlu F., Taş S., Çubukçu H. C., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.39, sa.4, ss.222-229, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.
MEDICINA-LITHUANIA , cilt.58, sa.11, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

NK-cell dysfunction of acute myeloid leukemia in relation to the renin-angiotensin system and neurotransmitter genes

TÜRK S., Baesmat A. S., YILMAZ A., TÜRK C., MALKAN Ü. Y., UÇAR G., et al.
OPEN MEDICINE , cilt.17, sa.1, ss.1495-1506, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Review on Characteristics and Analytical Methods of Rivaroxaban

REÇBER T., HAZNEDAROĞLU İ. C., ÇELEBİER M.
CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY , cilt.52, sa.4, ss.865-877, 2022 (SCI-Expanded) identifier identifier identifier

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded) identifier identifier identifier

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Bone Marrow Origin of Coronary Artery Diseases: The Impact of the Local Renin-Angiotensin System

KARAKULAK U. N., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
ACTA CARDIOLOGICA SINICA , cilt.38, sa.1, ss.13-20, 2022 (SCI-Expanded) identifier identifier identifier identifier

Leukemic stem cells shall be searched in the bone marrow before "tyrosine kinase inhibitor-discontinuation" in chronic myeloid leukemia

İLHAN O., Narli Ozdemir Z., DALVA K., ARSLAN A., Okay Ozgeyik M., Ipek S., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , cilt.43, sa.5, ss.1110-1116, 2021 (SCI-Expanded) identifier identifier identifier

Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia

ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.60, sa.2, 2021 (SCI-Expanded) identifier identifier identifier

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded) identifier identifier identifier

Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors

KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.
CARDIOVASCULAR TOXICOLOGY , cilt.21, sa.3, ss.216-223, 2021 (SCI-Expanded) identifier identifier identifier

Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation

Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Covid-19 scientific publications from Turkey

Ciftciler R., HAZNEDAROĞLU İ. C., TUFAN A., ÖZTÜRK M. A.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.3, ss.877-889, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?

ÇELEBİER M., HAZNEDAROĞLU İ. C.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , cilt.24, sa.4, ss.587-590, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Interferon-Gene Family Alterations Following the SARS-Cov Infection in Association with Iron Metabolism and Lymphoid Biology

Malkan Ü. Y., TÜRK S., Turk C., Temirci E. S., Koker I., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.2, ss.67-78, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey

SOYER N., ALİ R., Turgut M., HAZNEDAROĞLU İ. C., Yilmaz F., AYDOĞDU İ., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.3, ss.1033-1042, 2021 (SCI-Expanded) identifier identifier identifier identifier

Protein Kinases in Hematological Disorders

OKAY M., HAZNEDAROĞLU İ. C.
PROTEIN KINASE-MEDIATED DECISIONS BETWEEN LIFE AND DEATH , cilt.1275, ss.383-393, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Current community transmission and future perspectives on the COVID-19 process

TÜRK S., Turk C., Malkan Ü. Y., Temirci E. S., Peker M. C., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.3, ss.1001-1011, 2021 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content

BEYAZIT F., BEYAZIT Y., Tanoglu A., HAZNEDAROĞLU İ. C.
MEDICAL HYPOTHESES , cilt.143, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Pathobiological Interactions of Local Bone Marrow Renin-Angiotensin System and Central Nervous System in Systemic Arterial Hypertension

Ciftciler R., HAZNEDAROĞLU İ. C.
FRONTIERS IN ENDOCRINOLOGY , cilt.11, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature

ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.
MEDICINE , cilt.99, sa.26, 2020 (SCI-Expanded) identifier identifier identifier

In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus

Turk C., TÜRK S., Temirci E. S., Malkan Ü. Y., HAZNEDAROĞLU İ. C.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.21, sa.2, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors

OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.
LEUKEMIA & LYMPHOMA , cilt.61, ss.50-52, 2020 (SCI-Expanded) identifier

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors

HAZNEDAROĞLU İ. C., KUZU I., İLHAN O.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.1, ss.42-47, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

COVID-19, Renin-Angiotensin System, and Hematopoiesis

Ciftciler R., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.3, ss.207-208, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Ankaferd Hemostat Affects Etoposide Resistance of the Malignant Melanoma Cells

Ghasemi M., OKAY M., Malkan Ü. Y., TÜRK S., Jabbar J., Hocaoglu H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.1, ss.43-53, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy

Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , cilt.42, sa.1, ss.17-21, 2020 (SCI-Expanded) identifier identifier identifier

Local Bone Marrow Renin-Angiotensin System and COVID-19

Ciftciler R., Ciftciler A. E., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.2, ss.113-120, 2020 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat

HAZNEDAROĞLU İ. C., ÇELEBİER M.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.5, ss.1434-1435, 2020 (SCI-Expanded) identifier identifier identifier

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.11, ss.729-734, 2019 (SCI-Expanded) identifier identifier identifier

A unique case of complex variant translocation of t(6;9;22)(p22;q34;q11.2), der(19) in a newly diagnosed patient with chronic myeloid leukemia

Ciftciler R., Saglam E. A., Inanc A., Ozcebe O., HAZNEDAROĞLU İ. C.
CANCER GENETICS , cilt.237, ss.78-81, 2019 (SCI-Expanded) identifier identifier identifier

Ghosal hematodiaphyseal dysplasia with autoimmune anemia in two adult siblings

Ciftciler R., BÜYÜKAŞIK Y., Saglam E. A., HAZNEDAROĞLU İ. C.
TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.4, ss.449-452, 2019 (SCI-Expanded) identifier identifier identifier

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.20, sa.2, 2019 (SCI-Expanded) identifier identifier identifier

The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.

GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.
Journal Of The Renin-Angiotensin-Aldosterone System , 2019 (SCI-Expanded)

The impact of JAK/STAT inhibitor ruxolutinib on the genesis of lymphoproliferative diseases

TÜRK TÜRK S., HAZNEDAROĞLU İ. C., TÜRK C.
Turkish Journal Of Medical Sciences , 2019 (SCI-Expanded)

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded) identifier identifier identifier

Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency

ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.5, ss.1560-1563, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance

Ciftciler R., KOLUMAN A., HAZNEDAROĞLU İ. C., Akar N.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.1, ss.347-355, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Branch retinal vein occlusion associated with platelet activation

Beyazyildiz E., Citirik M., Simsek M., Beyazyildiz O., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.1, ss.283-287, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases

Turk C., OKAY M., TÜRK S., Temirci E. S., Javad O., AKSU S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.2, ss.661-674, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Current perspectives for the treatment of chronic myeloid leukemia

ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.1, ss.1-10, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia

Malkan U. Y., HAZNEDAROĞLU İ. C.
OPEN MEDICINE , cilt.14, sa.1, ss.22-24, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study

Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.2, ss.88-96, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Tumor Lysis Syndrome Due to Targeting of Hepatocellular Carcinoma Associated with Chronic Myelomonocytic Leukemia

OKAY M., ÇETİK S., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.3, ss.218-219, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

The factors affecting early death in newly diagnosed APL patients

Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE , cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach

KOÇAK E., ÇELEBİER M., HAZNEDAROĞLU İ. C., ALTINÖZ S.
BIOMED RESEARCH INTERNATIONAL , cilt.2019, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine

OKAY M., Ozturk Y., HAZNEDAROĞLU İ. C.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.25, 2019 (SCI-Expanded) identifier identifier identifier

Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded) identifier identifier identifier

On Being a "Physician Patient" with His Own Experimental Therapeutic Drug

Ciftciler R., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF HEMATOLOGY , cilt.35, sa.4, ss.302-303, 2018 (SCI-Expanded) Creative Commons License identifier identifier identifier

Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., ALİ R., GÜVENÇ B., et al.
HEMATOLOGY , cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded) identifier identifier identifier

Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded) Creative Commons License identifier identifier

The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.
LEUKEMIA & LYMPHOMA , cilt.58, ss.96, 2017 (SCI-Expanded) identifier

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases

Koluman A., Akar N., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.93-98, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms

SOYER N., HAZNEDAROĞLU İ. C., Comert M., Cekdemir D., YILMAZ M., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.27-33, 2017 (SCI-Expanded) Creative Commons License identifier identifier identifier

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

A myelofibrosis case that develops mycobacterial infection after ruxolitinib treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.4, ss.7304-7307, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Ankaferd hemostat induces DNA damage, apoptosis and cytotoxic activity by generating reactive oxygen species in melanoma and normal cell lines

KOÇYİĞİT A., GÜLER E. M., HAZNEDAROĞLU İ. C., Malkan Ü. Y.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.2, ss.2116-2126, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Lipotoxicity-Related Hematological Disorders in Obesity

HAZNEDAROĞLU İ. C., MALKAN Ü. Y.
OBESITY AND LIPOTOXICITY , cilt.960, ss.469-487, 2017 (SCI-Expanded) identifier identifier

Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis

Gunes H. N., Cokal B. G., Guler S. K., Yoldas T. K., Malkan Ü. Y., Demircan C. S., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.6, ss.1454-1461, 2016 (SCI-Expanded) identifier identifier identifier

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., ALİ R., GÜVENÇ B., et al.
EXPERT OPINION ON PHARMACOTHERAPY , cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded) identifier identifier identifier

Splenic artery embolization with Ankaferd blood stopper in a sheep model

KOÇ O., Acar K., Ozbek O., Guler I., Saritas K., Erdem T. B., et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.22, sa.4, ss.354-357, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan U. Y., GÜNEŞ G., ETGÜL S., Aslan T., Aydin S., HAZNEDAROĞLU İ. C.
ANNALS OF PHARMACOTHERAPY , cilt.50, sa.4, ss.336, 2016 (SCI-Expanded) identifier identifier identifier

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Molecular Management of Chronic Lymphocytic Leukemia: Towards a Chemotherapy-Free Approach

SAYINALP N., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.1-11, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Peripheral FLT-3 ligand levels as a pathobiological parameter during the clinical course of acute myeloid leukemia

Sahin M., HAZNEDAROĞLU İ. C., Ozbalci D.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.46, sa.6, ss.1889-1893, 2016 (SCI-Expanded) identifier identifier identifier

The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded) Creative Commons License identifier identifier

A CML case with resistant pleural effusion with tyrosine kinase inhibitor treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.14884-14887, 2016 (SCI-Expanded) identifier identifier

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

A Bing-Neel syndrome case

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.11, ss.22660-22663, 2016 (SCI-Expanded) identifier identifier

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Dasatinib-Induced Severe Hemorrhagic Colitis in Chronic Myeloid Leukemia

Kekilli M., Tanoglu A., Cakar M. K., Guney G., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.67-68, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems

BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

Koluman A., Akar N., Malkan U. Y., HAZNEDAROĞLU İ. C.
BIOMED RESEARCH INTERNATIONAL , cilt.2016, 2016 (SCI-Expanded) Creative Commons License identifier identifier identifier

Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia

ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY , cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded) identifier identifier identifier

High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology

BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded) identifier identifier identifier

Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., Aslan T., Balaban S., HAZNEDAROĞLU İ. C.
ANNALS OF PHARMACOTHERAPY , cilt.49, sa.6, ss.740-742, 2015 (SCI-Expanded) identifier identifier

In Vivo Healing Effects of Ankaferd Blood Stopper on the Residual Pancreatic Tissue in a Swine Model of Distal Pancreatectomy

Karaman K., Bostanci E. B., Celep B., Dincer N., Kurt M., Teke Z., et al.
INDIAN JOURNAL OF SURGERY , cilt.77, sa.3, ss.176-181, 2015 (SCI-Expanded) Creative Commons License identifier identifier

Severe radiation esophagitis successfully treated with Ankaferd hemostat

ÖZTÜRK Ö., KÖKLÜ S., BAŞAR Ö., HAZNEDAROĞLU İ. C.
GASTROINTESTINAL ENDOSCOPY , cilt.81, sa.4, ss.1048-1049, 2015 (SCI-Expanded) identifier identifier identifier

High iron content of Ankaferd hemostat as a clue for its hemostatic action of red blood cell origin

Akar N., Ardicoglu Y., ÖKTEM Z., ERDURAN N., HAZNEDAROĞLU İ. C.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.26, sa.2, ss.233-234, 2015 (SCI-Expanded) identifier identifier identifier

Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded) identifier identifier

Tryptophan in Molecular Hematopoiesis

HAZNEDAROĞLU İ. C.
TRYPTOPHAN METABOLISM: IMPLICATIONS FOR BIOLOGICAL PROCESSES, HEALTH AND DISEASE , ss.253-267, 2015 (SCI-Expanded) identifier

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms

ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded) identifier identifier

Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded) Creative Commons License identifier identifier identifier

Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) identifier

In vivo confocal microscopic characteristics of crystalline keratopathy in patients with monoclonal gammopathy: Report of two cases

KOCABEYOĞLU S., MOCAN M. C., HAZNEDAROĞLU İ. C., ÜNER A., UZUNOSMANOĞLU E., Irkec M.
INDIAN JOURNAL OF OPHTHALMOLOGY , cilt.62, sa.9, ss.938-940, 2014 (SCI-Expanded) identifier identifier identifier

Effective Management of Hemoptysis Via Endobronchial Application of Ankaferd Hemostat

UZUN O., Erkan L., HAZNEDAROĞLU İ. C.
ARCHIVOS DE BRONCONEUMOLOGIA , cilt.50, sa.9, ss.407-409, 2014 (SCI-Expanded) identifier identifier identifier

Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded) Creative Commons License identifier identifier

Next Generation Nanomedicine in the Genesis of "Ankaferd Blood Stopper Nanohemostat" A Novel Chimeric Topical Hemostatic Agent for Clinical Hemorrhages

Beyazit Y., Huri E., Purnak T., GÜLER M. Ö., HAZNEDAROĞLU İ. C.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.20, sa.4, ss.456-457, 2014 (SCI-Expanded) identifier identifier identifier

Ibrutinib: From Molecule to Medicine

Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier

An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature

Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded) Creative Commons License identifier identifier

Clinical Perspectives About the Molecular Management of B-Lymphoproliferative Neoplasms

HAZNEDAROĞLU İ. C., SAYINALP N.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.1-3, 2014 (SCI-Expanded) Creative Commons License identifier

Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)

AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded) Creative Commons License identifier identifier

The Efficiency of Ankaferd Blood Stopper During the Dental Surgery in Hemorrhagic Diathesis: Case Series

AKTAŞ A., ER N., KİRİŞ S., KÖSEOĞLU O. T., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.1, ss.60-64, 2014 (SCI-Expanded) Creative Commons License identifier identifier

As a Rare Presentation of Waldenstrom's Macroglobulinemia; Fever

Ozen M., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.3, ss.221-222, 2014 (SCI-Expanded) Creative Commons License identifier identifier

Clarification Letter Regarding the Gas Chromatography-Mass Spectrometry (GC-MS) Analyses of Ankaferd Hemostat, Published in UHOD 23: 171-177, 2013

HAZNEDAROĞLU İ. C., Beyazit Y., ÖZTÜRK Y., Demiralp D. O., Igci N.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.2, ss.148, 2014 (SCI-Expanded) Creative Commons License identifier identifier

Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature

Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded) Creative Commons License identifier

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

ŞAHİN F., SAYDAM G., Comert M., Uz B., Yavuz A., Turan E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.4, ss.351-358, 2013 (SCI-Expanded) Creative Commons License identifier

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded) identifier identifier identifier

Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever

Ozkayar N., Piskinpasa S., Akyel F., Dede F., YILDIRIM T., Turgut D., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.33, sa.10, ss.2555-2559, 2013 (SCI-Expanded) identifier identifier identifier

EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY , cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded) identifier identifier identifier

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia

Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis

Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded) identifier identifier identifier

ULTRASTRUCTURAL ANALYSES OF THE NOVEL CHIMERIC HEMOSTATIC AGENT GENERATED VIA NANOTECHNOLOGY, ABS NANOHEMOSTAT, AT THE RENAL TISSUE LEVEL

Huri E., HAZNEDAROĞLU İ. C., Hayran M., Ergun M., FIRAT A., Beyazit Y., et al.
HAEMATOLOGICA , cilt.98, ss.439, 2013 (SCI-Expanded) identifier

Circulating CD4+CD25+ Regulatory T Cells in the Pathobiology of Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis

Kekilli M., Tunc B., Beyazit Y., Kurt M., Onal I. K., Ulker A., et al.
DIGESTIVE DISEASES AND SCIENCES , cilt.58, sa.5, ss.1250-1255, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

Short-Term Effects of Ankaferd Hemostat for Renal Artery Embolization: An Experimental Study

Ozbek O., Acar K., Koc O., Saritas K., Toy H., SOLAK Y., et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY , cilt.36, sa.2, ss.498-504, 2013 (SCI-Expanded) identifier identifier identifier

Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis

HAZNEDAROĞLU İ. C., Beyazit Y.
CLINICAL SCIENCE , cilt.124, ss.307-323, 2013 (SCI-Expanded) identifier identifier identifier

Echocardiographic Dilemma: Misleading Thrombus Appearance Due to Cavitation With Intravascular Hemolysis on a Mechanical Prosthetic Valve

Akpinar I., Sayin M. R., KARABAĞ T., Kalkan M. E., DOĞAN S. M., AYDIN M., et al.
CANADIAN JOURNAL OF CARDIOLOGY , cilt.29, sa.3, 2013 (SCI-Expanded) identifier identifier identifier

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System

Akbal E., KÖKLÜ S., Astarci H. M., Kocak E., Karaca G., Beyazit Y., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , cilt.10, sa.4, ss.451-456, 2013 (SCI-Expanded) Creative Commons License identifier identifier identifier

Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis

Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines

Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded) Creative Commons License identifier identifier

The Fourier Transform Infrared (FTIR) Spectroscopic and Mass Spectrometric Metabolomics Studies of Ankaferd Hemostat

Demiralp D. O., Igci N., Ozturk Y., Beyazit Y., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.171-177, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Molecular Basis of Ankaferd-Induced Hemostasis in the Management of Sternal Bleeding

Beyazit Y., Sayilir A., Suvak B., Torun S., HAZNEDAROĞLU İ. C.
HEART SURGERY FORUM , cilt.15, sa.6, 2012 (SCI-Expanded) identifier identifier identifier

Prohemostatic and Antithrombin Activities of Ankaferd Hemostat Are Linked to Fibrinogen Gamma Chain and Prothrombin by Functional Proteomic Analyses

Ozel-Demiralp D., Igci N., Ayhan B., Egin Y., HAZNEDAROĞLU İ. C., Akar N.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.18, sa.6, ss.604-610, 2012 (SCI-Expanded) identifier identifier identifier

Effects of Ankaferd hemostat on the synovial fluid of patients with osteoarthritis

ÖZTÜRK M. A., KOÇAK TUFAN Z., Demirg M. D., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.42, sa.5, ss.768-772, 2012 (SCI-Expanded) Creative Commons License identifier identifier

Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD)

Yesil Y., Kuyumcu M. E., CANKURTARAN M., Uz B., Kara A., Kilic M. K., et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS , cilt.55, sa.2, ss.257-260, 2012 (SCI-Expanded) identifier identifier identifier

Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis

Leblebisatan G., Bay A., Karakus S. C., Kekilli M., HAZNEDAROĞLU İ. C.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.23, sa.6, ss.494-497, 2012 (SCI-Expanded) identifier identifier identifier

Controlling of upper gastrointestinal bleeding associated with severe immune thrombocytopenia via topical adjunctive application of Ankaferd blood stopper

Ozseker B., Shorbagi A., Efe C., HAZNEDAROĞLU İ. C., BAYRAKTAR Y.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.23, sa.5, ss.464, 2012 (SCI-Expanded) identifier identifier identifier

Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat

Haznedaroglu B. Z., Beyazit Y., Walker S. L., HAZNEDAROĞLU İ. C.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.83, sa.1, ss.21-34, 2012 (SCI-Expanded) identifier identifier identifier

Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML

AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded) Creative Commons License identifier

Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL

Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded) Creative Commons License identifier identifier

A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers

Balcik O. S., Koroglu M., Cipil H., Kaftan O., Maral S., Gurel A., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.4, ss.267-274, 2012 (SCI-Expanded) Creative Commons License identifier identifier

Striking Promotion of the In Vitro Myeloma Monoclonal Immunoglobulin Aggregation by Ankaferd Hemostat

Albayrak M., AKSU S., Celebi H., Albayrak A., Ginis Z., Yagci S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.15-22, 2012 (SCI-Expanded) Creative Commons License identifier identifier

Histopathological Alterations in the Kidney Tissue Following Topical Ankaferd Hemostat Application in a Rat Renal Injury Model

KARAKOÇ D., Akar E., AKSU S., ÜNER A., ÖZDEMİR A., HAMALOĞLU E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.4, ss.275-281, 2012 (SCI-Expanded) Creative Commons License identifier identifier

The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia

AKSU S., ŞAHİN F., Uz B., Yavuz S. A., Atay H., KELKİTLİ E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.22, sa.1, ss.8-14, 2012 (SCI-Expanded) Creative Commons License identifier

The effects of Ankaferd (R) Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile

YILMAZ E., Gulec S., Torun D., HAZNEDAROĞLU İ. C., Akar N.
TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.4, ss.276-285, 2011 (SCI-Expanded) Creative Commons License identifier identifier

Ankaferd Blood Stopper Is More Effective Than Adrenaline Plus Lidocaine and Gelatin Foam in the Treatment of Epistaxis in Rabbits

Kelles M., Kalcioglu M. T., ŞAMDANCI E., Selimoglu E., Iraz M., MİMAN M. C., et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL , cilt.72, sa.5, ss.185-194, 2011 (SCI-Expanded) identifier identifier

Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms

Beyazit Y., Purnak T., Suvak B., Kurt M., Sayilir A., Turhan T., et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.35, sa.10, ss.644-649, 2011 (SCI-Expanded) identifier identifier identifier

Percutaneous ankaferd injection to in vivo liver tissue in comparison to ethanol in an experimental rat model

Tas A., Koklu S., Beyazit Y., Karaca G., Astarci H. M., Akbal E., et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY , cilt.35, ss.549-553, 2011 (SCI-Expanded) identifier identifier identifier

Ankaferd hemostat in the management of gastrointestinal hemorrhages

Beyazit Y., Kekilli M., HAZNEDAROĞLU İ. C., KAYAÇETİN E., Basaranoglu M.
WORLD JOURNAL OF GASTROENTEROLOGY , cilt.17, sa.35, ss.3962-3970, 2011 (SCI-Expanded) identifier identifier identifier

Surgical and histopathological effects of topical Ankaferd (R) hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure

Ulus A. T., TURAN DURAL N. N., Ozyalcin S., Aydog G., Ulus F., GÖKER H., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.3, ss.206-212, 2011 (SCI-Expanded) Creative Commons License identifier identifier

Elevated Levels of Circulating Angiotensin Converting Enzyme in Patients with Hepatoportal Sclerosis

Beyazit Y., Ibis M., Purnak T., Turhan T., Kekilli M., Kurt M., et al.
DIGESTIVE DISEASES AND SCIENCES , cilt.56, sa.7, ss.2160-2165, 2011 (SCI-Expanded) identifier identifier identifier

Ankaferd hemostat for the management of tumoral GI bleeding

Beyazit Y., Kekilli M., Kurt M., Sayilir A., HAZNEDAROĞLU İ. C.
GASTROINTESTINAL ENDOSCOPY , cilt.73, sa.5, ss.1072-1073, 2011 (SCI-Expanded) identifier identifier identifier

Upper Gastrointestinal Bleeding in a Patient With Defective Hemostasis Successfully Treated with Ankaferd Blood Stopper

Purnak T., Ozaslan E., Beyazit Y., HAZNEDAROĞLU İ. C.
PHYTOTHERAPY RESEARCH , cilt.25, sa.2, ss.312-313, 2011 (SCI-Expanded) identifier identifier identifier

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

HAZNEDAROĞLU İ. C., Cetiner M., İLHAN O.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.21, sa.2, ss.1-3, 2011 (SCI-Expanded) Creative Commons License identifier identifier

EVALUATION OF A HAEMOSTATIC AGENT IN RABBITS

Turhan N., Bilgili H., Captug O., Kurt M., Shorbagi A., Beyazit Y., et al.
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES , cilt.8, sa.1, ss.61-65, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia

Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES , cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

Topical Ankaferd Bloodstopper in the Management of Critical Bleedings due to Hemorrhagic Diathesis

Turgut M., Tutkun F., Celebi N., MUĞLALI M., HAZNEDAROĞLU İ. C., GÖKER H.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.21, sa.3, ss.160-165, 2011 (SCI-Expanded) Creative Commons License identifier identifier

Pathobiological aspects of the local bone marrow renin-angiotensin system: a review

HAZNEDAROĞLU İ. C., Beyazit Y.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.11, sa.4, ss.205-213, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Evaluation of Hemostatic Effects of Ankaferd as an Alternative Medicine

Beyazit Y., Kurt M., Kekilli M., GÖKER H., HAZNEDAROĞLU İ. C.
ALTERNATIVE MEDICINE REVIEW , cilt.15, sa.4, ss.329-336, 2010 (SCI-Expanded) identifier identifier identifier

Successful treatment of endoscopic sphincterotomy-induced early hemorrhage with application of Ankaferd Blood Stopper

Beyazit Y., Koklu S., Akbal E., Kurt M., Kekilli M., HAZNEDAROĞLU İ. C.
GASTROINTESTINAL ENDOSCOPY , cilt.72, sa.6, ss.1325-1326, 2010 (SCI-Expanded) identifier identifier identifier

Do All Hemolytic Anemias That Occur After Mitral Valve Repair Require Surgical Treatment?

Gungunes A., Akpinar I., Dogan M., Baser K., Yildirim I. S., HAZNEDAROĞLU İ. C.
CLINICAL CARDIOLOGY , cilt.33, sa.12, 2010 (SCI-Expanded) identifier identifier identifier

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH , cilt.34, sa.12, 2010 (SCI-Expanded) identifier identifier identifier

Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an In Vivo Rabbit Experimental Model

Bilgili H., Captug O., Kosar A., Kurt M., Kekilli M., Shorbagi A., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.16, sa.5, ss.533-536, 2010 (SCI-Expanded) identifier identifier identifier

Atraumatic Osteonecrosis After Estrogen Replacement Therapy Associated with Low Protein S Level in a Patient with Turner Syndrome

Ureten K., Ozturk M. A., Bostanci A., Ceneli O., Oezbek M., HAZNEDAROĞLU İ. C.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.16, sa.5, ss.599-601, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage

Huri E., HAZNEDAROĞLU İ. C., Akgul T., Astarci M., Ustun H., Germiyanoulu C.
SAUDI MEDICAL JOURNAL , cilt.31, sa.8, ss.864-868, 2010 (SCI-Expanded) identifier identifier identifier

Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper

HAZNEDAROGLU B. Z., HAZNEDAROĞLU İ. C., WALKER S. L., Bilgili H., GÖKER H., Kosar A., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.16, sa.4, ss.446-453, 2010 (SCI-Expanded) identifier identifier identifier

Ankaferd Blood Stopper for Gastrointestinal Bleeding

Kurt M., Akdogan M., Ibis M., HAZNEDAROĞLU İ. C.
JOURNAL OF INVESTIGATIVE SURGERY , cilt.23, sa.4, ss.239, 2010 (SCI-Expanded) identifier identifier identifier

Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas

Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.96-102, 2010 (SCI-Expanded) identifier identifier

Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures

Kurt M., Onal I. K., Akdogan M., Kekilli M., Arhan M., Sayilir A., et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.24, sa.6, ss.380-384, 2010 (SCI-Expanded) Creative Commons License identifier identifier

Functional proteomic analysis of Ankaferd (R) Blood Stopper

Demiralp D. O., HAZNEDAROĞLU İ. C., Akar N.
TURKISH JOURNAL OF HEMATOLOGY , cilt.27, sa.2, ss.70-77, 2010 (SCI-Expanded) Creative Commons License identifier identifier

Increased circulating soluble P-selectin in polycystic ovary syndrome

Yildiz B. O., BOZDAĞ G., HARMANCI A., Otegen U., Boynukalin K., Vural Z., et al.
FERTILITY AND STERILITY , cilt.93, sa.7, ss.2311-2315, 2010 (SCI-Expanded) Creative Commons License identifier identifier identifier

Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens

SARIBAŞ Z., ŞENER B., HAZNEDAROĞLU İ. C., Hascelik G., Kirazli S., GÖKER H.
CENTRAL EUROPEAN JOURNAL OF MEDICINE , cilt.5, sa.2, ss.198-202, 2010 (SCI-Expanded) identifier identifier

Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery

ERCETIN S., HAZNEDAROĞLU İ. C., Kurt M., ONAL I. K., AKTAŞ A., KURT O. K., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.1, ss.1-5, 2010 (SCI-Expanded) identifier identifier

Endoscopic topical application of Ankaferd Blood Stopper for neoplastic gastrointestinal bleeding: A retrospective analysis

Kurt M., Akdogan M., Onal I. K., Kekilli M., Arhan M., Shorbagi A., et al.
DIGESTIVE AND LIVER DISEASE , cilt.42, sa.3, ss.196-199, 2010 (SCI-Expanded) identifier identifier identifier

The adhesion molecules of L-selectin and ICAM-1 in thrombocytosis and thrombocytopenia

Ulger Z., AKSU S., Aksoy D. Y., KÖKSAL D., HAZNEDAROĞLU İ. C., Kirazi S.
PLATELETS , cilt.21, sa.1, ss.49-52, 2010 (SCI-Expanded) identifier identifier identifier

Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY , cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded) identifier identifier identifier

Spinal Myeloid Sarcoma in Two Non-Leukemic Patients

Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE , cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded) Creative Commons License identifier identifier identifier

The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations

HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded) identifier identifier

Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML

BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded) identifier identifier

Retrospective Evaluation of Patients Treated with Dasatinib for Philadelphia Positive Leukemias: Turkish Experience of 16 Months

SAYDAM G., HAZNEDAROĞLU İ. C., Temiz Y., Soysal T., Sucak G., TOMBULOĞLU M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.19, sa.4, ss.195-204, 2009 (SCI-Expanded) Creative Commons License identifier identifier

Topical Ankaferd Blood Stopper Administration to Bleeding Gastrointestinal Carcinomas Decreases Tumor Vascularization

Turhan N., Kurt M., Shorbagi A., Akdogan M., HAZNEDAROĞLU İ. C.
AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.104, sa.11, ss.2874-2877, 2009 (SCI-Expanded) identifier identifier identifier

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY , cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded) identifier identifier identifier

Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability

Kurt M., Oztas E., KURAN S., Onal I. K., Kekilli M., HAZNEDAROĞLU İ. C.
AMERICAN JOURNAL OF EMERGENCY MEDICINE , cilt.27, sa.5, 2009 (SCI-Expanded) identifier identifier identifier

In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin

Cipil H. S., Kosar A., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.15, sa.3, ss.270-276, 2009 (SCI-Expanded) identifier identifier identifier

The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey

Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.2, ss.388-394, 2009 (SCI-Expanded) identifier

The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model

Kosar A., Cipil H. S., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.20, sa.3, ss.185-190, 2009 (SCI-Expanded) identifier identifier identifier

In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract

Akkoc N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , cilt.29, sa.2, ss.410-415, 2009 (SCI-Expanded) identifier identifier

MOLECULAR BASIS OF THE PLEIOTROPIC EFFECTS OF ANKAFERD BLOOD STOPPER

HAZNEDAROĞLU İ. C.
IUBMB LIFE , cilt.61, sa.3, ss.290, 2009 (SCI-Expanded) identifier

Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma

Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.
ONKOLOGIE , cilt.32, sa.11, ss.662-664, 2009 (SCI-Expanded) identifier identifier identifier

Thrombomodulin and GFC levels in Legg-Calve-Perthes disease

AKSOY M. C., Aksoy D. Y., HAZNEDAROĞLU İ. C., Sayinalp N., Kirazli S., Alpaslan M.
HEMATOLOGY , cilt.13, sa.6, ss.324-328, 2008 (SCI-Expanded) identifier identifier identifier

Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper Response

HAZNEDAROĞLU İ. C., GÖKER H.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.36, sa.6, ss.1448-1449, 2008 (SCI-Expanded) identifier

Successful Management of Bleeding Due to Solitary Rectal Ulcer via Topical Application of Ankaferd Blood Stopper

Ibis M., Kurt M., Onal I. K., HAZNEDAROĞLU İ. C.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE , cilt.14, sa.9, ss.1073-1074, 2008 (SCI-Expanded) identifier identifier identifier

Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients

BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded) identifier identifier identifier

Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma

Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY , cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded) identifier identifier identifier

Endoscopic application of Ankaferd blood stopper as a novel experimental treatment modality for upper gastrointestinal bleeding: A case report

Kurt M., Disibeyaz S., Akdogan M., Sasmaz N., AKSU S., HAZNEDAROĞLU İ. C.
AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.103, sa.8, ss.2156-2158, 2008 (SCI-Expanded) identifier identifier identifier

Severe arterial thrombophilia associated with a homozygous MTHFR gene mutation (A1298C) in a young man with Klinefelter syndrome

Ozbek M., Ozturk M. A., Ureten K., Ceneli O., ERDOĞAN M., HAZNEDAROĞLU İ. C.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.14, sa.3, ss.369-371, 2008 (SCI-Expanded) identifier identifier identifier

Evidence for higher red blood cell mass in persons with unconjugated Hyperbilirubinemia and Gilbert's syndrome

BÜYÜKAŞIK Y., Akman U., Buyukasik N. S., GÖKER H., Kilicarslan A., Shorbagi A. I., et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.335, sa.2, ss.115-119, 2008 (SCI-Expanded) identifier identifier identifier

Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis

Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded) identifier identifier identifier

Change in Blood Coagulation Parameters After Total Body Irradiation

CENGİZ M., GOEKER H., Yazici G., ZORLU F., BUEYUEKASIK Y., KIRAZLI S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.18, sa.3, ss.135-140, 2008 (SCI-Expanded) identifier identifier

Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis

HALİL M. G., Cankurtaran M., DOĞU B. B., Ulger Z., Piskinpasa S., Gedik A., et al.
ANNALS OF PHARMACOTHERAPY , cilt.41, sa.1, ss.41-45, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

The search for a common thrombophilic state during the active state of inflammatory bowel disease

Yurekli B. P. S., Aksoy D. Y., Aybar M., Egesel T., Gurgey A., Hascelik G., et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.40, sa.9, ss.809-813, 2006 (SCI-Expanded) identifier identifier identifier

Lack of association between familial Mediterranean fever and angiotensin converting enzyme gene polymorphism

Calguneri O., Ozturk M., Kiraz S., Ertenli I., Onat A., Ureten K., et al.
JOINT BONE SPINE , cilt.73, sa.3, ss.334-336, 2006 (SCI-Expanded) identifier identifier identifier

Changing clinical manifestations of a T-peripheral lymphoma: From hypereosinophilic syndrome to questionable Kimura's disease resulting in parotid mass

Beyazit Y., Haznedaroglu I., Aksu S., Kekilli M., ÜNER A., Agbaht K., et al.
LEUKEMIA & LYMPHOMA , cilt.47, sa.2, ss.357-360, 2006 (SCI-Expanded) identifier identifier identifier

Myocardial infarction and deep venous thrombosis in a young patient with Behcet disease

Calguneri M., Aydemir K., Ozturk M., Haznedaroglu I., Kiraz S., Ertenli I.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.12, sa.1, ss.105-109, 2006 (SCI-Expanded) identifier identifier identifier

Rethinking leptin and insulin action: Therapeutic opportunities for diabetes

Yildiz B., Haznedaroglu I.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , cilt.38, ss.820-830, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Overt gastrointestinal bleeding in haematologic neoplasms

Soylu A., Buyukasik Y., Cetiner D., Buyukasik N., Koca E., Haznedaroglu I., et al.
DIGESTIVE AND LIVER DISEASE , cilt.37, sa.12, ss.917-922, 2005 (SCI-Expanded) identifier identifier identifier

Complete cytogenietic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation

Koca E., Cetiner D., Goker H., Aksu S., Ozcebe O., Haznedaroglu I., et al.
CLINICAL NEPHROLOGY , cilt.64, sa.4, ss.324-326, 2005 (SCI-Expanded) identifier identifier identifier

Increased soluble glycoprotein V concentration during the acute onset of unstable angina pectoris in association with chronic cigarette smoking

Atalar E., Haznedaroglu I., Kilic H., Ozer N., Coskun S., Ozturk E., et al.
PLATELETS , cilt.16, sa.6, ss.329-333, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment

Halil M. G., CANKURTARAN M., YAVUZ B., OZKAYAR N., ULGER Z., DEDE D., et al.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.16, sa.5, ss.349-353, 2005 (SCI-Expanded) identifier identifier

Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease

Cemalettin M., Aksoy D., Haznedaroglu I., Sayinalp N., Kirazli S., Alpaslan M.
PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.22, sa.5, ss.391-399, 2005 (SCI-Expanded) identifier identifier identifier

Immediate effects of fluvastain on circulating soluble endothelial protein C and free tissue factor pathway inhibitor in acute coronary syndromes

Atalar E., Coskun S., Haznedaroglu I., Yucel N., Ozer N., Sivri B., et al.
CARDIOVASCULAR DRUGS AND THERAPY , cilt.19, sa.3, ss.177-181, 2005 (SCI-Expanded) identifier identifier identifier

Endogenous thrombopoietin levels during the clinical management of acute myeloid leukaemia

GÖNEN C., Haznedaroglu I., Aksu S., Koca E., Goker H., Buyukasik Y., et al.
PLATELETS , cilt.16, sa.1, ss.31-37, 2005 (SCI-Expanded) identifier identifier identifier

Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?

Erman M., Abali H., ORAN B., Haznedaroglu I., Canpinar H., KİRAZLI Ş., et al.
ANNALS OF ONCOLOGY , cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level

Cobankara V., Ozath D., Kiraz S., ÖZTÜRK A., Ertenli I., Turk T., et al.
CLINICAL RHEUMATOLOGY , cilt.23, sa.5, ss.430-434, 2004 (SCI-Expanded) identifier identifier identifier

Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders

Sayinalp N., Cinar H., ÜNER A., Haznedaroglu I., Buyukasik Y., Goker H., et al.
CLINICAL AND LABORATORY HAEMATOLOGY , cilt.26, sa.4, ss.265-268, 2004 (SCI-Expanded) identifier identifier identifier

The predictability of factor V Leiden (FV : Q(506)) gene mutation via clotting-based diagnosis of activated protein C resistance

Sayinalp N., Haznedaroglu I., Aksu S., Buyukasik Y., Goker H., Parlak H., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.10, sa.3, ss.265-270, 2004 (SCI-Expanded) identifier identifier identifier

Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia

Dizdar O., Yurekli B., Purnak T., Aksu S., Haznedaroglu I.
ANNALS OF PHARMACOTHERAPY , cilt.38, ss.1319-1320, 2004 (SCI-Expanded) identifier identifier identifier

Current debates in antiphospholipid syndrome: The acquired antibody-mediated thrombophilia

Ozturk M., Haznedaroglu I., Turgut M., Goker H.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.10, sa.2, ss.89-126, 2004 (SCI-Expanded) identifier identifier identifier

Angiotensin-converting enzyme gene polymorphism in Behcet's disease

Ozturk M., Calguneri M., Kiraz S., Ertenli I., Onat A., Ureten K., et al.
CLINICAL RHEUMATOLOGY , cilt.23, sa.2, ss.142-146, 2004 (SCI-Expanded) identifier identifier identifier

Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behcet's disease

Ozturk M., Ertenli I., Kiraz S., Haznedaroglu I., Celik I., Kirazli S., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.24, sa.2, ss.98-102, 2004 (SCI-Expanded) identifier identifier identifier

How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems

Ozturk M., Guven G., Haznedaroglu I.
MEDICAL HYPOTHESES , cilt.63, sa.5, ss.866-874, 2004 (SCI-Expanded) identifier identifier identifier

Protein C inhibitor and serum amyloid A in immune thrombocytopaenic purpura

Sayinalp N., Haznedaroglu I., Buyukasik Y., Goker H., Aksu S., Kocoglu H., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.32, sa.1, ss.62-65, 2004 (SCI-Expanded) identifier identifier identifier

Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia

Atalar E., Haznedaroglu I., Acil T., Ozer N., Kilic H., Ovunc K., et al.
PLATELETS , cilt.14, ss.407-411, 2003 (SCI-Expanded) identifier identifier identifier

Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis

Apras S., Ertenli I., Ozbalkan Z., Kiraz S., Ozturk M., Haznedaroglu I., et al.
ARTHRITIS AND RHEUMATISM , cilt.48, sa.8, ss.2256-2261, 2003 (SCI-Expanded) identifier identifier identifier

Decreased protein Z concentrations complicating the hypercoagulable state of Behcet's disease

Ozturk M., Ozbalkan Z., Onat A., Ertenli I., Kiraz S., Aytemir K., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.9, sa.3, ss.259-263, 2003 (SCI-Expanded) identifier identifier identifier

Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system

Haznedaroglu I., Ozturk M.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , cilt.35, sa.6, ss.867-880, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Pathologic thrombopoiesis of rheumatoid arthritis

Ertenli I., Kiraz S., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.
RHEUMATOLOGY INTERNATIONAL , cilt.23, sa.2, ss.49-60, 2003 (SCI-Expanded) identifier identifier identifier

Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Calguneri M., Atalar E., et al.
JOURNAL OF RHEUMATOLOGY , cilt.30, sa.2, ss.313-315, 2003 (SCI-Expanded) identifier identifier identifier

Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Kirazli S., et al.
CLINICAL RHEUMATOLOGY , cilt.21, sa.6, ss.453-456, 2002 (SCI-Expanded) identifier identifier identifier

Thrombopoietin inside the pulmonary vessels in patients with and without pulmonary hypertension

Haznedaroglu I., Atalar E., Ozturk M., Ozer N., Ovunc K., Aksoyek S., et al.
PLATELETS , cilt.13, sa.7, ss.395-399, 2002 (SCI-Expanded) identifier identifier identifier

Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists

Abali H., Gullu I., Engin H., Haznedaroglu I., Erman M., Tekuzman G.
MEDICAL HYPOTHESES , cilt.59, sa.3, ss.344-348, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state

Yildiz B., Haznedaroglu I., Kirazli S., Bayraktar M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.87, sa.8, ss.3871-3875, 2002 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Thrombopoietin as a drug: Biologic expectations, clinical realities, and future directions

Haznedaroglu I., Goker H., Turgut M., Buyukasik Y., Benekli M.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.8, sa.3, ss.193-212, 2002 (SCI-Expanded) identifier identifier identifier

Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease

Buyukasik Y., Karakus S., Goker H., Haznedaroglu I., Ozatli D., Sayinalp N., et al.
BLOOD COAGULATION & FIBRINOLYSIS , cilt.13, sa.4, ss.349-353, 2002 (SCI-Expanded) identifier identifier identifier

Hemostatic parameters in Behcet's disease: a reappraisal

Kosar A., Ozturk M., Haznedaroglu I., Karaaslan Y.
RHEUMATOLOGY INTERNATIONAL , cilt.22, sa.1, ss.9-15, 2002 (SCI-Expanded) identifier identifier identifier

Proinflammatory and hematopoietic cytokines in reactive and clonal thrombycytosis

Ozturk M., Kiraz S., Ertenli I., Calguneri M., Haznedaroglu I.
SOUTHERN MEDICAL JOURNAL , cilt.95, sa.5, ss.565-566, 2002 (SCI-Expanded) identifier identifier identifier

Piebaldism associated with congenital dyserythropoietic anemia type II (HEMPAS)

Koklu S., Ertugrul D., Onat A., Karakus S., Haznedaroglu I., Buyukasik Y., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.69, sa.3, ss.210-213, 2002 (SCI-Expanded) identifier identifier identifier

Plasma thrombospondin in immune thrombocytopenic purpura

Ozcebe O., Karakus S., Haznedaroglu I., Goker H., Kosar A., Kocoglu H., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.30, sa.1, ss.52-55, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

Effects of extracorporeal circulation on thrombin-antithrombin III and prothrombin fragment 1+2 levels

Yilmaz M., Haznedaroglu I., Kirazli S., Pasaoglu I.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.8, sa.1, ss.61-63, 2002 (SCI-Expanded) identifier identifier identifier

Pathological haemostasis and 'prothrombotic state' in Behcet's disease

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.
THROMBOSIS RESEARCH , cilt.105, sa.2, ss.125-133, 2002 (SCI-Expanded) identifier identifier identifier

Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behcet's disease: evidence of a prethrombotic state

Ozatli D., Sayinalp N., Buyukasik Y., Karakus S., Haznedaroglu I., Kirazli S., et al.
RHEUMATOLOGY INTERNATIONAL , cilt.21, sa.4, ss.137-140, 2002 (SCI-Expanded) identifier identifier identifier

Plasma thrombopoietin in patients with cavernous transformation of the portal vein

Goker H., Egesel T., Karakus S., Haznedaroglu I., Apras S., Buyukasik Y., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY , cilt.75, sa.1, ss.91-94, 2002 (SCI-Expanded) identifier identifier identifier

Hyperhomocysteinaemia and activated protein C resistance in Behcet's disease

Altinbas A., Aytemur K., Tokgozoglu L., Ozturk M., Kosar A., Haznedaroglu I., et al.
JOURNAL OF INTERNAL MEDICINE , cilt.248, sa.3, ss.267-268, 2000 (SCI-Expanded) identifier

The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis

Birdane A., Haznedaroglu I., Ozath D., Sayinalp N., Kosar A., Buyukasik Y., et al.
EXPERIMENTAL HEMATOLOGY , cilt.28, sa.7, ss.120, 2000 (SCI-Expanded) identifier

Behcet's disease.

Haznedaroglu I., Ozcebe O., Dundar S.
NEW ENGLAND JOURNAL OF MEDICINE , cilt.342, sa.8, ss.588, 2000 (SCI-Expanded) identifier

A unifying hypothesis for the renin-angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway

Haznedaroglu I., Arici M., Buyukasik Y.
MEDICAL HYPOTHESES , cilt.54, sa.1, ss.80-83, 2000 (SCI-Expanded) identifier

Serum L-selectin and P-selectin levels in lymphomas

Haznedaroglu I., Benekli M., Ozcebe O., Savas M., Gullu IH G. I., Dundar S., et al.
HAEMATOLOGIA , cilt.30, sa.1, ss.27-30, 2000 (SCI-Expanded) identifier

Aplastic pancytopenia associated with thymoma [2]

Coplu L., Selcuk Z., Haznedaroglu I., Dogan R., Gungen Y.
Annals of Hematology , cilt.79, sa.11, ss.648-650, 2000 (SCI-Expanded) identifier identifier identifier

Selectin adhesion molecules in Behcet's disease

Haznedaroglu S., Karaaslan Y., Buyukasik Y., Kosar A., Ozcebe O., Haznedaroglu I., et al.
ANNALS OF THE RHEUMATIC DISEASES , cilt.59, sa.1, ss.61-63, 2000 (SCI-Expanded) Creative Commons License identifier

Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever

KİRAZ S., ERTENLİ A. İ., ARICI M., Calguneri M., HAZNEDAROĞLU İ. C., ÇELİK İ., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.16, sa.6, ss.721-724, 1998 (SCI-Expanded) identifier identifier identifier

Diğer Dergilerde Yayınlanan Makaleler

IMMUNOGENOMIC APPROACH TO THE CLINICAL MANAGEMENT OF COVID-19 SYNDROME

TÜRK S., HAZNEDAROĞLU İ. C., TÜRK C., malkan ü. y.
Eskisehir Medical Journal, Eskisehir City Hospital , 2023 (Hakemli Dergi)

Pharmacobiology of topical Ankaferd hemostat in neoplastic disorders

Malkan U. Y., Haznedaroglu I. C.
The European Research Journal , cilt.9, sa.5, ss.1271-1276, 2023 (Hakemli Dergi) Creative Commons License identifier

Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

GÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.
Acta Medica , cilt.54, sa.2, ss.97-102, 2023 (Hakemli Dergi) Creative Commons License identifier

Exposure of Hepatocellular Carcinoma Cells to Ankaferd Blood Stopper (R) Alters Cell Death Signaling Networks Confirmed by Oncoproteomic and Genomic Profiling Studies

NENNİ M., ÖNCÜL S., ERCAN A., ÇELEBİER M., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
CURRENT TRADITIONAL MEDICINE , cilt.7, sa.2, ss.223-235, 2021 (ESCI) identifier identifier

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

Ciftciler R., Ciftciler A. E., Malkan Ü. Y., HAZNEDAROĞLU İ. C.
SAGE OPEN MEDICINE , cilt.8, 2020 (ESCI) identifier identifier

Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
HEMATOLOGY REPORTS , cilt.12, sa.1, 2020 (ESCI) Creative Commons License identifier identifier identifier

Effects of Smoking on Hematological Parameters and Ferritin Levels

Ciftciler R., Guven A., HAZNEDAROĞLU İ. C., AKSU S.
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.57, sa.4, ss.372-376, 2019 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

CYTOGENETIC ANOMALIES IN MULTIPLE MYELOMA PATIENTS: A SINGLE CENTER STUDY

BOZKURT S., BÜYÜKAŞIK Y., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., KARATAŞ A., et al.
Genetics and Application , cilt.3, sa.1, ss.51-56, 2019 (Hakemli Dergi)

Waldenstrom macroglobulinemia presenting as plasma cell leukemia associated with hyperviscosity syndrome

ÇİFTÇİLER R., SAĞLAM E. A., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C.
Medical Science and Discovery , cilt.5, sa.12, ss.390-392, 2018 (Hakemli Dergi) Creative Commons License

Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
Journal of Global Oncology , ss.205, 2018 (ESCI)

Farklı Trombositopeni Sebeplerinin Klinik ve Laboratuvar Bulguları

AKIN S., AKIN Ş., Karaağaç A. T., HAZNEDAROĞLU İ. C.
Journal of Contemporary Medicine , cilt.7, sa.4, ss.316-322, 2017 (Hakemli Dergi) Creative Commons License

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper

ŞİMŞEK C., Selek S., Koca M., HAZNEDAROĞLU İ. C.
SAGE OPEN MEDICINE , cilt.5, 2017 (ESCI) identifier

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

TÜRK TÜRK S., Malkan Ü. Y., Ghasemi M., Hocaoglu H., Mutlu D., Gunes G., et al.
SAGE OPEN MEDICINE , cilt.5, 2017 (ESCI) identifier identifier

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.9, ss.61-64, 2016 (ESCI) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., HAZNEDAROĞLU İ. C.
CASE REPORTS IN HEMATOLOGY , 2015 (ESCI) Creative Commons License identifier

Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML)

HAZNEDAROĞLU İ. C.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , cilt.6, sa.1, 2014 (ESCI) identifier identifier

Generation of Chimeric "ABS Nanohemostat'' Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model

Huri E., Beyazit Y., Mammadov R., Toksoz S., TEKİNAY A. B., GÜLER M. Ö., et al.
INTERNATIONAL JOURNAL OF BIOMATERIALS , cilt.2013, 2013 (ESCI) Creative Commons License identifier identifier

THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.74, sa.1, ss.7-12, 2011 (ESCI) identifier

DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE

Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.73, sa.3, ss.74-79, 2010 (ESCI) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Determination of Drug Sensitivity Subgroups in Acute Myeloblastic Leukemia by the Detection of Gene Based Cancer Biomarkers and the Prediction of Prognosis and Treatment.

TÜRK TÜRK S., TÜRK C., HAZNEDAROĞLU İ. C., SAYINALP N.
The Febs Congress, 6 - 11 Temmuz 2019 Sürdürülebilir Kalkınma

Proteomic Investigation of In-Vitro Antineoplastic Effect of Ankaferd Hemostat with 2D Gel Electrophoresis and MALDI-TOF/TOF-MS in HepG2, Caco-2 and HT-29 Cancer Cells

NENNİ M., ÇELEBİER M., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
The International Society on Thrombosis and Hemostasis (ISTH), 6 - 10 Temmuz 2019 Sürdürülebilir Kalkınma

Proteomic Investigation of Ankaferd Hemostat Application on MCF-7 Breast Cancer Cell Line

ZEKİ Ö. C., NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., HAZNEDAROĞLU İ. C.
International Multidisciplinary Symposium on Drug Research and Development (DRD), 1 - 03 Temmuz 2019 Sürdürülebilir Kalkınma

THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE

SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, İsviçre, 18 - 22 Haziran 2019, cilt.37, ss.366

ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ

AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019

ALLOJENİK KÖK HÜCRE NAKLİ SONRASI RELAPS İZLENEN AKUT LÖSEMİ HASTALARINDA TEDAVİ SEÇENEKLERİ: DONÖR LENFOSİT İNFUZYONU VE İKİNCİ ALLOJENİK KÖK HÜCRE NAKLİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., ÇİFTÇİLER R., SAYINALP N., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019

MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ

ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Türkiye, 8 - 09 Mart 2019

Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients

ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132 identifier

DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.364-365 Sürdürülebilir Kalkınma

MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.266

LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018

LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192

AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI

ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.261

PRİMER VE EDİNSEL İMMÜN YETMEZLİĞİ OLAN HASTALARDA MALİGNİTE SIKLIĞI

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., SAYINALP N.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.276-277

T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ

DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018

Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patient with myelofibrosis: updated data

SOYER N., ALİ R., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., et al.
9. International Eurasian Hematology Oncology Congress, 17 - 20 Ekim 2018

BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE

DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.
IX. INTERNATIONAL EHOC, 17 - 20 Ekim 2018, cilt.73

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73 Creative Commons License identifier identifier identifier

Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73 identifier

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018

RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018

AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE

ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Kıbrıs (Kktc), 19 - 23 Eylül 2018, ss.254

EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018

Investigation of The Effect of Commercial Herbal Mixture on HepG2 Liver Cancer Cell Line by Proteomic Approach

NENNİ M., ÖNCÜL S., ERCAN A., SÜSLÜ İ., ÇELEBİER M., HAZNEDAROĞLU İ. C.
12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018 Sürdürülebilir Kalkınma

DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA

AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018

Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data

AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.
European Hemtology Association, 14 - 17 Haziran 2018

PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ

ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018

Common medical problems in adult patients with Hemophilia A: A single center experience

AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.
15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Türkiye, 4 - 07 Nisan 2018

Echocardiographic Evaluation of Patients with Hodgkin and Non Hodgkin Lymphoma before and after Hematopoietic Stem Cell Transplantation

KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H., ŞAHİNER M. L., OKAY M., AYDIN M. S., et al.
59th ASH, 9 - 12 Aralık 2017, cilt.130, ss.5521

Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.
LYMPHOMA AND MYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.43-44

Donor Lymphocyte Infusions: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.
LYMPHOMAMYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.48

The Modelled Effetiveness oh Ruxolitinib on survival in PV Patients with Hydroxyurea Resistance /Intolerancein Turkey

BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.
ISPOR 20th Annual Eurepean Congress, 4 - 08 Kasım 2017

Epidemiological Estimatesand Treatment Practice Pattern in Polycytemia Vera Patients in Turkey:Results Based on an Expert Panel

BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., ÖZET G., Ar C., Özcan M., Güvenç B., et al.
ISPOR 20th Annual European Congress, 4 - 08 Kasım 2017

kronik myeloproliferatif neoplazili hastalarda ruksolitinib etkinlik ve güvenliği: çok merkezli ve geriye dönük çalışma

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.
43.ulusal hematoloji kongresi, Türkiye, 1 - 04 Kasım 2017

KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDA RUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VE GERİYE DÖNÜK ÇALIŞMA.

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017

Donor Lymhocyte Infusion: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.
LYMHOMA MYELOMA 2017, 26 - 28 Ekim 2017

Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.
LYMPHOMA MYELOMA 2017, 26 - 28 Ekim 2017

Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., yılmaz f., AYDOĞDU İ., PİR A., et al.
AHOS, 21 - 24 Eylül 2017

Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ F., AYDOĞDU İ., PİR A., et al.
4th Aegean Hematology Oncology Symposium, 21 - 24 Eylül 2017

EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS

DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, cilt.53

Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.

malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.
XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Almanya, 08 Temmuz 2017 - 13 Ocak 2018, cilt.1, ss.402

The Impact of Chemo/Immune Therapy-­‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.
iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017

Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017

Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374 identifier

Determination of chemoterapoetic drugsensitivity subgroups of acute leukemia

Türk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.
The FEBS Journal, 3 - 08 Eylül 2016

AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIB

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., HAZNEDAROĞLU İ. C., DEMİROĞLU H., GÖKER H.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

A COMPOSITE LYMPHOMA CASE

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

A CHRONIC MYELOID LEUKEMIA CASE WHO HAS DISCONTINUED IMATINIB TREATMENT

Malkan Ü. Y., GÜNEŞ G., Aslan T., Yayar O., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

AN ACUTE MYELOID LEUKEMIA PATIENT COMPLICATED WITH HYPERLEUKOCYTOSIS

Malkan Ü. Y., GÜNEŞ G., Yayar O., HAZNEDAROĞLU İ. C., AKSU S., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

THERAPY-RELATED MYELODYSPLASTIC SYNDROME AFTER THE SUCCESSFUL TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

Malkan Ü. Y., GÜNEŞ G., Yayar O., AKSU S., DEMİROĞLU H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINE

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

A PLASMA CELL LEUKEMIA CASE

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

TREATMENT OF PYODERMA GANGRENOSUM WITH THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., Yayar O., Aslan T., AKSU S., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39 identifier

Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124 identifier

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124 identifier

Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study

Avcu F., Guner M., Misirci M., Elci P., Safali M., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124 identifier

GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014

Ultrastructural analyses of novel chimeric nanohemostat generated via peptide nanofibers and ABS hemostat at the renal tissue level

HURİ E., HAZNEDAROĞLU İ. C., FIRAT A., ERGUN K. M., HAYRAN H. M.
18th Congress EHA, Stockholm, İsviçre, 13 - 18 Haziran 2013

Cytogenetic and Molecular Response to Imatinib in High Risk (Sokal) Chronic Myeloid Leukemia (CML): Results of An European Leukemianet Prospective Study Comparing 400 Mg and 800 Mg Front-Line

Baccarani M., Castagnetti F., Simonsson B., Porkka K., HAZNEDAROĞLU İ. C., Nagler A., et al.
50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2008, cilt.112, ss.75-76 identifier

Haemostatic actions of the folkloric medicinal plant extract, Ankaferd Blood Stopper

GÖKER H., HAZNEDAROĞLU İ. C., Ercetin S., Kirazli S., Akman U., Ozturk Y., et al.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110 identifier

Over-expression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.

Beyazit Y., Aksu S., Haznedaroglu I., Kekilli M., Misirlioglu M., Tuncer S., et al.
47th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 10 - 13 Aralık 2005, cilt.106 identifier

Levels of the circulating leukemia inhibitory factor in patients with vasculitis

Ozbalkan Z., Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Ureten K., et al.
Annual European Congress of Rheumatology, Lisbon, Portekiz, 18 Haziran 2003, cilt.62, ss.447-448 identifier

Thrombopoietin levels in the pulmonary vessels in patients with and without pulmonary hypertension.

Haznedaroglu I., Atalar E., Kocoglu M., Aksu S., Goker H., Buyukasik Y., et al.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 Aralık 2002, cilt.100 identifier

Eozinofili ile Seyreden Anjiolenfoid Hiperplazi: Bir Olgu Sunumu

AKSOY B., HAZNEDAROĞLU İ. C., ŞAHİN S., Bükülmez G., GÖKÖZ Ö., Gököz A., et al.
IV. Çukurova Dermatoloji Günleri, Adana, Türkiye, 30 Mayıs - 02 Haziran 2002

Kitap & Kitap Bölümleri

HMGB1-targeting herbal medicinal plant extracts for the phytotherapy of cancer and potential management of COVID-19

REÇBER T., HAZNEDAROĞLU İ. C., ÇELEBİER M.
HMGB1: Functions, Inhibitors, and Clinical Significance, TAŞKIN EYLEM, GÜVEN CELAL, KAYA SALİH TUNÇ, Editör, Nova Science Publishers, ss.3-42, 2022

Klinik Pratikte Hematoloji

HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.
nobel tıp kitabevleri, Ankara, 2019

Metrikler

Yayın

331

Atıf (WoS)

2778

H-İndeks (WoS)

29

Atıf (Scopus)

920

H-İndeks (Scopus)

14

Proje

11

Tez Danışmanlığı

2

Açık Erişim

90
BM Sürdürülebilir Kalkınma Amaçları